157670-28-5

Basic information

• Product Name: Pyridine, 2-chloro-5-ethenyl- (9CI)
• Synonyms: Pyridine, 2-chloro-5-ethenyl- (9CI);2-Chloro-5-vinyl-pyridine;2-Chloro-5-ethenylpyridine;Pyridine, 2-chloro-5-ethenyl-
• CAS NO: 157670-28-5
• Molecular Formula: C₇H₆ClN
• Molecular Weight: 139.58224
• Product Categories: PYRIDINE
• Mol File: 157670-28-5.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 212.6±20.0 °C(Predicted)
• Appearance: /
• Density: 1.157±0.06 g/cm3(Predicted)
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• PKA: -0.23±0.10(Predicted)
• CAS DataBase Reference: Pyridine, 2-chloro-5-ethenyl- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Pyridine, 2-chloro-5-ethenyl- (9CI)(157670-28-5)
• EPA Substance Registry System: Pyridine, 2-chloro-5-ethenyl- (9CI)(157670-28-5)

Safety Data

• Hazardous Substances Data: 157670-28-5(Hazardous Substances Data)

Usage

General Description

Pyridine, 2-chloro-5-ethenyl- (9CI) is a chemical compound with the molecular formula C7H6ClN. It is a chlorinated derivative of pyridine, which is a colorless liquid with a fish-like odor. It is commonly used as a solvent in organic synthesis and as a reagent in various chemical reactions. It is also used in the manufacturing of pharmaceuticals, pesticides, and dyes. Additionally, it is known for its potential health effects, as it is considered toxic if inhaled, ingested, or exposed to the skin. Therefore, proper handling and safety precautions are necessary when working with this compound.

Upstream product

• 23100-12-1 6-chloronicotinylaldehyde 
• 1779-49-3 Methyltriphenylphosphonium bromide 
• 27200-84-6 methyl triphenylphosphonium bromide 
• 53939-30-3 5-bromo-2-chloropyridine 
• 75927-49-0 pinacol vinylboronate 
• 69045-79-0 2-choro-5-iodopyridine 
• 7486-35-3 tri-n-butyl(vinyl)tin 
• 5326-23-8 6-Chloro-3-pyridinecarboxylic acid 

Relevant articles and documents

BENZYLAMINOPYRIDYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

The present invention relates to compounds of general formula (I) wherein the groups R, R1, R2, R3, m and n are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2. Furthermore, the invention relates to novel intermediates, useful for the synthesis of compounds of formula (I).

TRICYCLIC GUANIDINE DERIVATIVE

Disclosed are compounds useful as inhibitors of Phosphodiesterase 1 (PDE1), compositions thereof, and methods of using the same.

Sulfamide derivatives useful as beta3 agonists and pharmaceutical uses thereof

Sulfamide compounds having formula (I) are described as well as their use in the treatment of diseases dependent on the signaling pathways associated with β-adrenergic receptors, such as obesity, diabetes, hypertension, gastrointestinal hypo- or hyper-motility and cardiovascular diseases.